Intratumoral nanobody–IL-2 fusions that bind the tumor extracellular matrix suppress solid tumor growth in mice is a research paper published in PNAS Nexus (2022). On theSindex it has a DataRank of 0.520. It has been cited 31 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.520
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: P30-CA14051
NCI NIH HHS
Grant: P30 CA014051
National Institute of Biomedical Imaging and Bioengineering
Grant: R01EB031082
National Computational Infrastructure
Grant: CA174795
NCI NIH HHS
Grant: R01 CA174795
NCI NIH HHS
Grant: T32 CA079443
NIH HHS
Grant: S10 OD016326
National Science Foundation
Grant: 0070319
Development of Multi-User Facility for the Study of Complex Macromolecular Systems
National Institutes of Health
Grant: 1S10OD016326-01A1
Acquisition of Octet Biolayer Interferometry system for MIT biophysics facility
National Institutes of Health
Grant: 1R01EB031082-01A1
Localized immunotherapy using alum-binding therapeutics
National Institutes of Health
Grant: 5P30CA014051-17
CELL BIOLOGY--DEVELOPMENTAL PROGRAM
National Institutes of Health
Grant: 4R01CA174795-04
Localizing Immunotherapy to Improve Therapeutic Index
FWCI
3.02
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals